comparemela.com

Latest Breaking News On - Revvity - Page 1 : comparemela.com

Revvity (NYSE:RVTY) PT Raised to $130.00 at TD Cowen

Revvity (NYSE:RVTY – Free Report) had its price target increased by TD Cowen from $123.00 to $130.00 in a research note issued to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages also recently issued reports on RVTY. Stifel Nicolaus boosted their price objective on […]

Prahladr-singh
Stifel-nicolaus
Life-sciences
Securities-exchange-commission
Benjaminf-edwards-company-inc
Keycorp
Revvity-inc
Barclays
Parkside-financial-bank
Free-report
Moderate-buy
Get-free-report

Revvity (NYSE:RVTY) Price Target Raised to $127.00

Revvity (NYSE:RVTY – Get Free Report) had its price target upped by analysts at Robert W. Baird from $126.00 to $127.00 in a research note issued on Tuesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price objective points to a potential upside of 23.78% from the company’s […]

Prahladr-singh
Robertw-baird
Stifel-nicolaus
Northern-trust-corp
Asset-management-co
Capital-research-global-investors
Norges-bank
Keycorp
Revvity-inc
Vanguard-group-inc
Mitsubishi-ufj
Life-sciences

Penobscot Investment Management Company Inc. Acquires Shares of 2,000 Revvity, Inc. (NYSE:RVTY)

Penobscot Investment Management Company Inc. bought a new stake in Revvity, Inc. (NYSE:RVTY – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,000 shares of the company’s stock, valued at approximately $219,000. Several other hedge funds have also recently made […]

New-jersey
United-states
Alabama
Prahladr-singh
Robertw-baird
Stifel-nicolaus
Penobscot-investment-management-company-inc
Truist-financial-corp
Exchange-commission
Revvity-inc
Life-sciences
Russell-investments-group-ltd

Levin Capital Strategies L.P. Invests $896,000 in Revvity, Inc. (NYSE:RVTY)

Levin Capital Strategies L.P. bought a new position in shares of Revvity, Inc. (NYSE:RVTY – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 8,200 shares of the company’s stock, valued at approximately $896,000. Several other institutional investors and hedge funds have […]

Switzerland
Swiss
Raymond-james
Stifel-nicolaus
Prahladr-singh
Robertw-baird
Life-sciences
Exchange-commission
Ceredex-value-advisors
Sumitomo-mitsui-trust-holdings-inc
Vanguard-group-inc
Revvity-inc

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript April 29, 2024 Revvity, Inc. beats earnings expectations. Reported EPS is $0.98, expectations were $0.94. Revvity, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to the Q1 2024 […]

China
Chinese
Max-krakowiak
Our-life-sciences-instrument
Tour-life-sciences
Specialty-pharma-services
Life-sciences
Reagents-technology-licensing
Our-signal-software
Revvity-omics-lab
Investor-relations
Life-sciences-instrument

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.